Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Nature Chemical Biology|December 5, 2017
Human antibody-based chemically induced dimerizers for cell therapeutic applicationsZachary B Hill, Alexander J Martinko, Duy P Nguyen, et al.Current Pharmaceutical Design|December 25, 2009
Development of agents that modulate protein-protein interactions in membranesTina X Zhao, Alexander J Martinko, Vy H Le, et al.Journal of the American Chemical Society|November 7, 2018
Engineering Improved Antiphosphotyrosine Antibodies Based on an Immunoconvergent Binding MotifYun Mou, Xin X Zhou, Kevin Leung, et al.Journal of Medicinal Chemistry|May 20, 2011
Development of β-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antisepticsSherry A Chavez, Alexander J Martinko, Corinna Lau, et al.ACS Medicinal Chemistry Letters|September 9, 2010
Selection, Preparation, and Evaluation of Small- Molecule Inhibitors of Toll-Like Receptor 4Douglas E Bevan, Alexander J Martinko, Lisa C Loram, et al.Elife|January 24, 2018
Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteinsAlexander J Martinko, Charles Truillet, Olivier Julien, et al.Proceedings of the National Academy of Sciences of the United States of America|February 25, 2018
Highly multiplexed and quantitative cell-surface protein profiling using genetically barcoded antibodiesSamuel B Pollock, Amy Hu, Yun Mou, et al.Proceedings of the National Academy of Sciences of the United States of America|February 25, 2022
Switchable assembly and function of antibody complexes in vivo using a small moleculeAlexander J Martinko, Erin F Simonds, Suchitra Prasad, et al.Chembiochem : a European Journal of Chemical Biology|February 3, 2009
A peptide antagonist of the TLR4-MD2 interactionPeter F Slivka, Mitesh Shridhar, Gui-in Lee, et al.The Journal of Clinical Investigation|February 15, 2022
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancersShion A Lim, Jie Zhou, Alexander J Martinko, et al.Pageof 2